International Patent: HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF

GENEVA, Aug. 31 -- SHANGHAI QILU PHARMACEUTICAL RESEARCH AND DEVELOPMENT CENTRE LTD. filed a patent application (CN2026/079372) for “HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF”. With publication no. WO/2026/175369, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 471/04

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....